Impact Of Rising Prevalence Of Vascular Heart Diseases On The Mitral Valve Disease Market Driver: Leading Transformation in the Mitral Valve Disease Market in 2025

What Are the Projected Growth and Market Size Trends for the Mitral Valve Disease Market?
In the past few years, the market size for mitral valve disease has seen a formidable growth. It is projected to increase from $3 billion in 2024 to $3.3 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The historic growth can be credited to efforts in patient education, robust reimbursement policies and insurance coverage, escalating expenditure on healthcare, increasing vigilance and screening initiatives along with a growing market footprint.

In the upcoming years, robust growth is anticipated in the mitral valve disease market size. The market is projected to expand to $4.73 billion in 2029, registering a compound annual growth rate (CAGR) of 9.4%. This growth during the forecast period can be credited to the increasing incidence of mitral valve disease, the acceptance of minimally invasive techniques, surging advancements in heart valve surgery, growth of venture capital investments, and enhanced interest from manufacturers. Crucial trends expected during this period encompass technological progression, advancements in transcatheter technologies, and the rise of technological advancements in surgical procedures.

What Are the Main Catalysts for Growth in the Mitral Valve Disease Market?
Expectations are that the mitral valve disease market will grow due to the rising incidence of vascular heart diseases. These represent a range of conditions that impact the blood vessels that supply the heart or those located within the heart itself. The uptick in vascular heart diseases is triggered by a confluence of factors, including lifestyle choices, shifting demographics, medical conditions, environmental influences, and genetic variables. By negatively affecting the structure and functions of the heart, vascular heart diseases such as ischemic heart disease and hypertension can indirectly cause mitral valve disease. For example, data from the Australian Bureau of Statistics 2020-21 highlights this. In a National Health Survey carried out by the Australian Institute of Health and Welfare, a government agency based in Australia, they reported that the death rate from cardiovascular disease per 100,000 population saw an increase from 143.7 in 2021 to 148.2 in 2022 among males. So, the growth in the mitral valve disease market is certainly fueled by the rising prevalence of vascular heart diseases.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

Which Leading Companies Are Shaping the Growth of the Mitral Valve Disease Market?
Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

What Are the Major Trends Shaping the Mitral Valve Disease Market?
Major corporations in the mitral valve disease market are innovating with the production of stented tissue valves to cater to the increasing requirement for minimally invasive medical solutions. Stented tissue valves are engineered to offer reliable and resilient performance, serving as an alternate to conventional surgical procedures. For instance, in April 2024, Medtronic, a healthcare firm based in Ireland, unveiled the Avalus Ultra valve. This avant-garde surgical aortic tissue valve is crafted for improved convenience during implantation and extensive patient care. With the experience of over ten years with the original Avalus valve, the Avalus Ultra comes with a compact valve profile for simpler implantation, a PEEK base frame for maintaining circularity, and topping the industry with Effective Orifice Area (EOA) to potentially boost blood circulation. Furthermore, it encompasses a radiopaque coil for unambiguous visibility during future valve-in-valve operations.

What Are the Key Segments of the Mitral Valve Disease Market?
The mitral valve disease market covered in this report is segmented -

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair
2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)
3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing
4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

Which Region Dominates the Mitral Valve Disease Market?
Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Mitral Valve Disease Global Market Report?

- Market Size Analysis: Analyze the Mitral Valve Disease Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Mitral Valve Disease Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Mitral Valve Disease Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Mitral Valve Disease Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16480

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.